On 17 January 2018
Jubilant Life Sciences will hold a meeting of the Board of Directors of the Company on 17 January 2018, to consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content